Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

This study tested if adding a new drug called TQA3605 to standard hepatitis B medications works better than the standard drugs alone. It involved 122 adults with chronic hepatitis B who still had low levels of the virus in their blood despite treatment. The main goal was to see i…

This early-stage trial tested a new oral drug called AL2846 for people with an advanced form of thyroid cancer. The cancer had stopped responding to both radioactive iodine and at least one other targeted cancer drug. The main goal was to see if AL2846 could shrink tumors and to …

This study tested whether a new injectable medication called TQC2731 could help adults with severe asthma that remains poorly controlled despite standard treatments. Over 200 participants received either one of three doses of TQC2731 or a placebo injection every four weeks for a …

This study tested a new oral medication called TQ05105 for patients with a severe complication of stem cell transplants called acute graft-versus-host disease (aGVHD) that does not respond to standard steroid treatment. The main goals were to check the drug's safety, how well the…

This early-stage study aimed to understand how the body absorbs, breaks down, and eliminates an experimental drug called TQ05105. Six healthy male volunteers received a single, traceable dose of the drug. Researchers then carefully measured how much of the drug and its breakdown …

This early-stage study aimed to understand how a potential new drug for myelofibrosis (a bone marrow disorder) interacts with other common medications that can speed up or slow down drug processing in the body. It involved 40 healthy volunteers who received single doses of the st…

This early-stage study aimed to understand how a new antibiotic combination (TQD3606) is processed by the body in people with varying levels of kidney function. It enrolled 32 adults, comparing those with healthy kidneys to those with mild, moderate, or severe kidney disease. The…

This early-stage study tested how a new antibiotic called TQD3524 behaves in the body of people with different levels of kidney function. Researchers gave a single dose to 48 adults with healthy kidneys or with mild to severe kidney disease. The main goal was to measure how the d…

This study tested if a new version of a drug called eltrombopag, used to treat low platelet counts, works the same way in the body as the original version. It involved 36 healthy Chinese volunteers who took both versions of the pill after a meal. The main goal was to compare how …